(Q80035754)

English

Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetolo

scientific article published on 24 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17384924%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259-267 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17384924%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

P D Home

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17384924%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

24 March 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17384924%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17384924%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

50

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17384924%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17384924%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1561-2; author reply 1563-4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17384924%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

https://scigraph.springernature.com/pub.10.1007/s00125-007-0653-9

0 references

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/17384924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17384924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17384924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17384924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17384924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17384924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17384924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17384924

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80035754&oldid=1531254446"